Submit Deal

Announced

31 Jan 2019

Completed

31 Jan 2019

Ginkgo Bioworks acquired the genome mining business of Warp Drive Bio.

Synopsis

Sale by Warp Drive Bio, a biotechnology company and subsidiary of Revolution Medicines, of its genome mining business to Ginkgo Bioworks, a biotech company founded in 2009 by scientists from MIT headed by Tom Knight. Financial terms were not disclosed.

Principals

target

Genome Mining Business Of Warp Drive Bio

bidder

Ginkgo Bioworks

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

Sort

Bidder Team (1)

tom knight

Founder at GINKGO BIOWORKS INC

Manager

bidder

Deal

n/a

Total Value

Vendor Team (5)

chad rolston

Partner at Latham & Watkins

Lawyer

vendor

Deals

£ 44.82 B

Total Value

mark roeder

Partner at Latham & Watkins

Lawyer

vendor

Deals

£ 8.83 B

Total Value

chad rolston

Partner at Latham & Watkins

Lawyer

vendor

Deals

£ 44.82 B

Total Value

mark a. goldsmith

President and CEO at REVOLUTION MEDICINES INC

Manager

vendor

Deals

£ 979 M

Total Value

mark roeder

Partner at Latham & Watkins

Lawyer

vendor

Deals

£ 8.83 B

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy